RAPIGLINIDE VOG 1.0

If you live with type 2 diabetes, you may have noticed that the numbers that worry you most often come after eating. The fasting reading looks acceptable, but a thali of rice, roti, dal and a sweet can push the glucometer high within two hours. Some people also find that their sugar rises when meals are irregular, because the medicine they take does not match the timing of their food. RAPIGLINIDE VOG 1.0 from Steris Healthcare Pvt. Ltd. is designed around mealtimes. It combines repaglinide, which helps the pancreas release insulin quickly when food arrives, with voglibose, which slows the absorption of carbohydrates from the meal. This guide explains what the tablet contains, why it matters, its benefits, precautions and side effects, and how to buy it responsibly.

Product Information

Brand Name: RAPIGLINIDE VOG 1.0
Composition: Repaglinide 1 mg + Voglibose 0.3 mg
Manufacturer/Marketer: Steris Healthcare Pvt. Ltd.
Dosage Form: Tablet
Pack Size: 15 tablets
Drug Classes: Meglitinide (insulin secretagogue) + alpha-glucosidase inhibitor
Therapeutic Category: Anti-diabetic (oral combination therapy)
Prescription Status: Prescription required (Rx)
Primary Use: Management of type 2 diabetes mellitus in adults, particularly to control post-meal (postprandial) blood glucose
Target Market: India

What Is RAPIGLINIDE VOG 1.0?

RAPIGLINIDE VOG 1.0 is a fixed-dose combination of two anti-diabetic ingredients that both focus on the period after a meal, but in different ways.

Repaglinide (1 mg) belongs to the meglitinide class, sometimes called “glinides.” It stimulates the beta cells of the pancreas to release insulin. Its action begins quickly and wears off within a few hours, so it is taken around meals to match the rise in blood sugar after eating. Because it also raises insulin levels, it can cause low blood sugar if a meal is delayed or skipped.

Voglibose (0.3 mg) is an alpha-glucosidase inhibitor. It works in the small intestine, where it temporarily slows the enzymes that break complex carbohydrates down into glucose. Sugar from the meal therefore enters the bloodstream more gradually, which softens the post-meal peak. Very little voglibose is absorbed into the blood, so it acts mainly in the gut.

Together, repaglinide boosts mealtime insulin while voglibose reduces the amount of glucose arriving at once. The pairing targets the post-meal spike from two directions.

Why It Is Important

1. Post-meal spikes carry real long-term risk. Repeated high glucose after meals can contribute to damage in the eyes, kidneys, nerves and blood vessels. Controlling these spikes is an important part of bringing HbA1c into the range your doctor has set.

2. It matches medicine to meals. Both ingredients act around food. For people whose eating pattern is regular, this can be a logical way to focus treatment where the problem is largest.

3. It suits carbohydrate-rich Indian diets. Rice, wheat, potatoes, sweets and snacks make up a large share of daily calories for many families, so a medicine that moderates carbohydrate absorption and supports mealtime insulin is especially relevant.

4. It offers flexibility for people with variable meal timing. Repaglinide is taken with meals, and a dose is generally omitted when a meal is omitted. This can suit people whose schedules change, though your doctor will advise you on exactly how to handle skipped meals.

5. It can be an option when other drugs are not suitable. Doctors sometimes consider glinide-based regimens for patients who cannot take certain other drug classes. The decision depends on your overall health, kidney function and other medicines.

6. It can reduce pill burden. One tablet in place of two separate medicines can make the daily routine simpler and reduce missed doses.

7. It supports complication prevention. Staying within your HbA1c target lowers the risk of neuropathy, retinopathy, kidney disease and cardiovascular problems.

Key Benefits 

• Better control of post-meal glucose: Repaglinide supports a quick insulin response, while voglibose slows carbohydrate absorption.
• Fast onset, short duration: Repaglinide acts quickly and wears off within hours, which is why it is linked to mealtimes rather than to the whole day.
• Complementary mechanisms: One ingredient works on insulin release and the other on glucose absorption in the gut.
• Flexibility with meals: The dose is generally tied to meals, which can help when eating times vary, as long as your doctor’s instructions are followed.
• Low weight-gain tendency from voglibose: Voglibose is generally weight-neutral, although insulin-stimulating medicines can cause some weight gain in certain people.
• Convenience: Two medicines in one tablet simplifies the routine.
• Established ingredients: Both repaglinide and voglibose have been used in clinical practice for many years, so doctors have considerable experience with them.
• Useful add-on option: Your doctor may combine this tablet with other anti-diabetic medicines such as metformin when needed.

How It Is Usually Taken

Your doctor will decide the dose and timing based on your blood sugar readings, kidney and liver function, diet and other medicines. Combinations containing repaglinide and voglibose are generally taken shortly before a meal, because both ingredients need to be active when food is being digested. The timing window and number of doses per day depend on your prescription, so follow your doctor’s instructions and the pack leaflet.

A key rule for this type of tablet is to link the dose to the meal. If you skip a meal, ask your doctor whether you should also skip that dose, since taking it without food can cause low blood sugar. If you miss a dose, do not take a double dose later. Swallow the tablet with water, and do not crush or chew it unless your doctor says it is acceptable.

Precautions: What to Tell Your Doctor and Keep in Mind

Do not use this medicine if you:

• Have type 1 diabetes, diabetic ketoacidosis or diabetic coma
• Are allergic to repaglinide, voglibose or any other ingredient in the tablet
• Have severe liver disease
• Take gemfibrozil (a cholesterol-lowering medicine), which is known to interact seriously with repaglinide and raise its levels in the body
• Have intestinal obstruction, a history of partial obstruction, severe inflammatory bowel disease or chronic digestive disorders affecting absorption

Use with caution and under medical supervision if you:

• Are elderly, because the risk of low blood sugar is higher
• Have kidney problems or mild to moderate liver problems
• Eat irregularly or skip meals often
• Have had abdominal surgery or bowel problems
• Have adrenal, pituitary or thyroid problems, which can affect blood sugar
• Are pregnant, planning pregnancy or breastfeeding. Your doctor will advise the safest option, and this type of medicine is generally not preferred in pregnancy
• Take other medicines, including clopidogrel, certain antifungals and antibiotics, rifampicin, carbamazepine, other anti-diabetic drugs, beta-blockers, steroids, or herbal supplements. These can raise or lower the effect of repaglinide or change your blood sugar

Possible Side Effects

Most people tolerate these medicines well, though side effects can occur, especially in the first few weeks.

Common side effects:

• Gas, flatulence and abdominal bloating (more typical with voglibose)
• Stomach discomfort or cramps
• Nausea, loose stools or diarrhoea
• Mild headache or dizziness
• Upper respiratory symptoms such as a blocked nose or sore throat (reported with repaglinide)

Less common but important:

• Low blood sugar (hypoglycaemia), mainly due to repaglinide
• Weight gain
• Constipation
• Joint or back pain
• Skin rash, itching or allergic reactions
• Changes in liver enzyme levels on blood tests

Frequently Asked Questions

1. What are repaglinide and voglibose tablets?

Repaglinide and voglibose tablets are a fixed-dose combination anti-diabetic medicine used in adults with type 2 diabetes mellitus, along with a healthy diet and regular physical activity. Repaglinide belongs to the meglitinide class. It helps the pancreas release insulin quickly when food is eaten, and its action wears off within a few hours. Voglibose is an alpha-glucosidase inhibitor that slows the digestion of carbohydrates in the small intestine, so sugar enters the blood more gradually. Together, they target the rise in blood sugar after meals. Because repaglinide can cause low blood sugar, the dose is linked to meals. It is a prescription-only medicine.

2. What is the composition of repaglinide and voglibose tablets?

RAPIGLINIDE VOG 1.0 contains:

• Repaglinide 1 mg
• Voglibose 0.3 mg

Inactive ingredients (excipients) can differ between brands, so please check the pack label and leaflet for the complete composition.

3. Which company manufactures repaglinide and voglibose tablets in India?

RAPIGLINIDE VOG 1.0 is manufactured and marketed by Steris Healthcare Pvt. Ltd. Several other Indian pharmaceutical companies may also sell this combination under their own brand names. Always confirm the manufacturer name, batch number and licence details printed on the pack.

4. Where can I find a supplier of repaglinide and voglibose tablets?

You can source these tablets from:

• Licensed retail chemists and hospital pharmacies (for personal use with a valid prescription)
• Registered pharmaceutical wholesalers and distributors
• Licensed online pharmacies that display a valid drug licence number
• The manufacturer or its authorised marketing team, through official contact channels

Before ordering, verify the supplier’s drug licence, GST registration and physical address. Avoid sellers who do not ask for a prescription or cannot show valid licences.

5. How can I buy repaglinide and voglibose tablets in bulk?

Bulk purchase is usually done through a licensed wholesaler or distributor, or directly from the manufacturer or its authorised channel. Pharmacies, hospitals, clinics and distributors generally need to provide:

• A valid wholesale or retail drug licence
• GST number and business details
• Required quantity and pack size (RAPIGLINIDE VOG 1.0 comes in a pack of 15 tablets)
• Delivery location

Ask for a tax invoice showing batch numbers and expiry dates with every consignment. Individual patients should not stock up in bulk without medical advice, since the tablets expire and require a prescription.

6. What is the price of repaglinide and voglibose tablets?

The price depends on the brand, pack size, pharmacy and location. RAPIGLINIDE VOG 1.0 is available in a pack of 15 tablets, and the MRP printed on the pack is the maximum retail price. Wholesale rates and bulk discounts differ by supplier and order quantity. Please confirm the current price with the manufacturer, a licensed distributor or your local chemist, as prices can change.

7. Can pharmaceutical distributors order these tablets wholesale?

Yes, licensed distributors and wholesalers can generally place wholesale orders with the manufacturer or its authorised channels. You will typically need to share your wholesale drug licence, GST details and the territory you serve. Minimum order quantity, margins, credit terms and delivery timelines are set by the company, so contact the marketer directly to discuss them.

8. Which pharmaceutical companies offer third-party manufacturing for these tablets?

Many Indian contract and loan-licence manufacturers produce oral anti-diabetic tablets for other brands, especially in pharma hubs such as Baddi (Himachal Pradesh), Haridwar (Uttarakhand), Ahmedabad and Vadodara (Gujarat) and Hyderabad (Telangana). I cannot verify which specific companies currently offer this combination, so I recommend that you:

• Confirm the manufacturer holds a valid manufacturing licence and WHO-GMP or equivalent certification
• Ask about product-specific capability, minimum order quantity, batch size and stability data
• Request regulatory documents and, where possible, audit the facility
• Check the combination’s approval status with the Indian drug regulator

Third-party manufacturing of prescription fixed-dose combinations must comply with CDSCO and state drug authority regulations.

9. How can I request a quotation for repaglinide and voglibose tablets?

Contact the manufacturer or a licensed supplier through their official email, phone number or enquiry form, and include:

• Your company name and business type (distributor, pharmacy, hospital and so on)
• Drug licence and GST numbers
• Product name and composition (RAPIGLINIDE VOG 1.0, Repaglinide 1 mg and Voglibose 0.3 mg tablets)
• Pack size and required quantity
• Delivery location and expected timeline

Request the quotation in writing and ask for its validity period, payment terms and applicable taxes.

10. Where can I find the product specifications for these tablets?

Product specifications are available from:

• The pack label and the package insert inside the carton
• The manufacturer’s official website or product catalogue
• The marketer’s sales or regulatory team on request
• Your pharmacist or prescribing doctor

Key details to check include composition and strengths, dosage form (tablet), pack size, storage conditions, shelf life, batch number and manufacturing and expiry dates. Institutional buyers and distributors can also ask the manufacturer for a product data sheet or certificate of analysis.